Velcade

Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
Wed, 02/13/13 - 10:16 am
JNJ
Multiple Myeloma
Velcade
Celgene
Revlimid
AbbVie
ONYX Pharmaceuticals
Bristol-Myers Squibb
Watson challenges patent on cancer drug Velcade
PharmPro
Sat, 12/29/12 - 10:35 am
Watson
Velcade
patents
generics
Watson challenges patent on cancer drug Velcade
Yahoo/AP
Fri, 12/28/12 - 11:29 am
Watson Pharmaceuticals
Velcade
Millennium
Multiple Myeloma
FDA OKs subcutaneous use of Takeda cancer drug
Reuters
Tue, 01/24/12 - 10:44 am
FDA
Takeda
cancer
Velcade
Millennium withdraws cancer drug application
Bizjournals.com
Thu, 10/6/11 - 11:56 am
Millennium
Velcade
follicular lymphoma
JNJ
J&J Fails to Win Appeal of U.K. Backing of Rival’s Thalidomide
Bloomberg
Thu, 06/16/11 - 10:17 pm
JNJ
thalidomide
Celgene
Velcade
Johnson & Johnson, Takeda Units Recall Velcade Drug After Particle Reports
Bloomberg
Fri, 11/19/10 - 11:17 am
JNJ
Takeda
Velcade
VELCADE(R) (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens
istockanalyst
Sun, 12/6/09 - 11:09 am
Velcade
Multiple Myeloma
Celgene Cancer Pill to Triple Sales on Threat to J&J
Bloomberg
Mon, 11/30/09 - 11:05 am
Celgene
JNJ
cancer
Revlimid
Velcade
FDA To Review Takeda’s sNDA For Velcade
Pharmaceutical Business Review
Fri, 09/4/09 - 07:48 am
Takeda
sNDA
Velcade
FDA
Multiple Myeloma
Millennium rebuked by FDA over labeling
Bizjournals.com
Thu, 06/25/09 - 05:04 pm
Millennium
FDA
Velcade
Multiple Myeloma Research Consortium (MMRC) and Merck Initiate Phase II Trial of Zolinza with Velcade in Relapsed and Refractory Multiple Myeloma Patients
Earth Times
Sat, 01/17/09 - 09:01 am
Merck
Zolinza
Velcade
Multiple Myeloma

Pages